Navellier & Associates’s Argan AGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$30.5M Buy
38,247
+8,364
+28% +$5.56M 2.42% 10
2026
Q1
$16.3M Sell
29,883
-6,225
-17% -$2.54M 1.7% 12
2025
Q4
$11.3M Sell
36,108
-2,334
-6% -$741K 1.27% 17
2025
Q3
$10.4M Buy
38,442
+12,040
+46% +$2.76M 1.05% 21
2025
Q2
$5.82M Buy
26,402
+6,558
+33% +$1.18M 0.72% 32
2025
Q1
$3.28M Sell
19,844
-8,126
-29% -$1.13M 0.45% 62
2024
Q4
$3.83M Buy
27,970
+20,047
+253% +$2.75M 0.46% 55
2024
Q3
$804K Buy
7,923
+1,761
+29% +$139K 0.11% 166
2024
Q2
$451K Buy
+6,162
New +$404K 0.05% 262
2017
Q3
Sell
-14,780
Closed -$887K 234
2017
Q2
$887K Buy
14,780
+435
+3% +$28.1K 0.13% 144
2017
Q1
$949K Buy
14,345
+10,597
+283% +$742K 0.14% 142
2016
Q4
$264K Buy
+3,748
New +$234K 0.04% 240

Other funds holding AGX

Navellier & Associates's AGX Position: Q2 2026 in Review

Navellier & Associates increased its Argan (AGX) stake by 28% in Q2 2026, buying an estimated $5.56M and bringing the position to 38,247 shares worth $30.5M. The position accounts for 2.42% of the portfolio, ranked #10.

Navellier & Associates first reported a position in AGX in Q4 2016 and has held it in 12 quarters since. 566 funds tracked by Wall St. Rank hold AGX as of Q2 2026.

  • Navellier & Associates held 38,247 shares of Argan worth $30.5M as of Q2 2026.
  • Navellier & Associates bought 8,364 Argan shares in Q2 2026, an estimated $5.56M.
  • Argan made up 2.42% of Navellier & Associates's portfolio in Q2 2026, its #10 holding.
  • Navellier & Associates first reported a position in Argan in Q4 2016 and has held it in 12 quarters since.
  • 566 funds tracked by Wall St. Rank held Argan as of Q2 2026.

Based on Navellier & Associates's 13F filing for Q2 2026, filed 4 Aug 2026.